PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9511724-8	1998	Long-term treatment with either the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) or bryostatin 1 inhibited levels of Dsg1 and Dsg3, but not Dsg2 in NHEKs and HaCaT cells.	Tetradecanoylphorbol Acetate	50-86	desmoglein 3	Homo sapiens	138-142	
9511724-8	1998	Long-term treatment with either the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) or bryostatin 1 inhibited levels of Dsg1 and Dsg3, but not Dsg2 in NHEKs and HaCaT cells.	Tetradecanoylphorbol Acetate	88-91	desmoglein 3	Homo sapiens	138-142	
9511724-9	1998	Chronic TPA also decreased Dsg1 and Dsg3 mRNA levels in NHEKs, further supporting a role for PKC activation in the expression of the suprabasal Dsg1 and Dsg3.	Tetradecanoylphorbol Acetate	8-11	desmoglein 3	Homo sapiens	36-40	
9511724-9	1998	Chronic TPA also decreased Dsg1 and Dsg3 mRNA levels in NHEKs, further supporting a role for PKC activation in the expression of the suprabasal Dsg1 and Dsg3.	Tetradecanoylphorbol Acetate	8-11	desmoglein 3	Homo sapiens	153-157